• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

16
2
2
1
1

COUNTRY

2
1

CATEGORIES

  • 30
  • 22
  • 16
  • 14
  • 8
  • 6
  • 6
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

13
54
76
105

PUBLISHED

1
6
27
105

PRODUCT TYPE

64
33
6
2

Search "Disease and Therapy Review: Crohn's Disease" returned 105 results.

Crohn's Disease Global Clinical Trials Review, H1, 2015

Crohn's Disease Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Crohn's Disease Global Clinical Trials Review, H1, 2015" provides data on the Crohn’s Disease clinical trial...

January 2015
FROM

Crohn's Disease - Pipeline Review, H2 2014

Crohn's Disease - Pipeline Review, H2 2014 Summary This, ‘Crohn's Disease - Pipeline Review, H2 2014’, provides an overview of the Crohn's Disease’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Crohn's Disease - Pipeline Review, H1 2014

Crohn's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2014’, provides an overview of the Crohn's Disease’s therapeutic pipeline. This...

February 2014
FROM
Crohn’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015 Crohn’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015 - Product Thumbnail Image

Crohn’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015

“Crohn’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015” is an essential source of information and analysis on the global Crohn’s disease market The report identifies the key trends shaping...

December 2009
FROM
ChemoCentryx's and GSK's Traficet-EN (Vercirnon) for Crohn's Disease ChemoCentryx's and GSK's Traficet-EN (Vercirnon) for Crohn's Disease - Product Thumbnail Image

ChemoCentryx's and GSK's Traficet-EN (Vercirnon) for Crohn's Disease

ChemoCentryx’s and Glaxo Smith Kline's (GSK) Traficet-EN is an oral small molecule in late stage development for the treatment of Crohn’s Disease Three pivotal studies and an open label study are underway...

July 2012
FROM

Autoimmune Diseases - Pipelines for Crohn’s Disease, Multiple Sclerosis and Rheumatoid Arthritis

This report focuses on current and pipeline candidate therapeutics and their respective targets for three autoimmune diseases and answers such questions as: - Who are the companies with active development...

July 2011

Disease & Therapy Review (DTR) Executive Market Summaries

Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently Each report includes epidemiology from the IPD (Incidence...

May 2015

Genisphere Inc. - Product Pipeline Analysis, 2013 Update

Summary Genisphere Inc. (Genisphere) is a biotechnology company. The company manufactures kits used for the ultra-sensitive detection of nucleic acids and proteins. Genisphere's therapeutic areas include...

October 2013
FROM

Quanterix Corporation - Product Pipeline Analysis, 2013 Update

Summary Quanterix Corporation (Quanterix) is a medical device company. The company develops and provides ultra-sensitive detection systems for use in research and in-vitro diagnostics. Its products...

July 2013
FROM
Cell Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

July 2015
FROM

Adaptive Biotechnologies Corporation - Product Pipeline Analysis, 2013 Update

Summary Adaptive Biotechnologies Corporation (Adaptive) is a biotechnology company. The company develops next generation sequencing assays for the adaptive immune system. It offers immunoSEQ, a suite...

October 2013
FROM

Entyvio (Crohn's Disease) - Forecast and Market Analysis to 2022

Entyvio (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will...

January 2014
FROM

Autoimmune Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns...

October 2011
FROM
Crohn's Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Crohn's Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Product Thumbnail Image

Crohn's Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Crohn’s Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Crohn’s Disease (CD) Therapeutics...

December 2011
FROM

Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)

Stem Cell Therapeutics Markets There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading...

October 2014
FROM

Quanterix Corporation - Product Pipeline Analysis

Summary Quanterix Corporation (Quanterix) is a medical device company, based in the US. The company develops and provides ultra-sensitive detection systems for use in research and in-vitro diagnostics....

November 2012
FROM

Adaptive Biotechnologies Corporation - Product Pipeline Analysis, 2014 Update

Summary Adaptive Biotechnologies Corporation (Adaptive) is a biotechnology company. The company develops next generation sequencing assays for the adaptive immune system. It offers immunoSEQ assay....

June 2014
FROM

Autoimmune Disease Partnering Terms and Agreements

"The Autoimmune Disease Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune disease partnering deals and agreements entered into by...

March 2015
FROM

Adaptive Biotechnologies Corporation - Product Pipeline Analysis.

Summary Adaptive Biotechnologies Corporation(Adaptive), formerly known as Adaptive TCR Corporation, develops sequencing assays for the adaptive immune system. With the help of its patent-pending technology,...

January 2013
FROM
Stem Cell Therapeutics Markets Stem Cell Therapeutics Markets - Product Thumbnail Image

Stem Cell Therapeutics Markets

Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S....

February 2009
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group